Skip to main content
logo
Addex Therapeutics logo
Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
2.650
-0.360 (-11.96%)
At close: Oct 14, 2026, 4:00 PM EDT
2.690
+0.040 (1.51%)
After-hours: Oct 14, 2026, 4:56 PM EDT

Addex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
38671143
Market Cap Growth
-65.00%31.23%-15.45%-34.64%-74.03%-28.14%
Enterprise Value
2532027
Last Close Price
3.017.727.006.0512.60125.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.80---
PS Ratio
34.8337.3613.723.827.1912.50
PB Ratio
1.521.360.585.402.112.33
P/TBV Ratio
1.521.360.585.402.112.33

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
26.7724.925.661.080.287.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.010.000.300.080.03
Net Debt / Equity Ratio
-0.36-0.34-0.34-3.07-1.34-1.18
Net Debt / EBITDA Ratio
0.270.571.291.580.631.32
Net Debt / FCF Ratio
0.290.740.610.440.401.36
Asset Turnover
0.010.020.050.250.090.15
Quick Ratio
0.581.384.191.392.305.03
Current Ratio
0.761.404.421.462.385.31
Return on Equity (ROE)
-150.58%-94.75%-90.72%-82.53%-98.92%-97.35%
Return on Assets (ROA)
-27.12%-20.64%-22.48%-21.69%-42.75%-45.37%
Return on Capital Employed (ROCE)
-122.90%-54.50%-27.90%-128.30%-210.80%-84.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-237.47%-104.18%125.46%-170.78%-200.32%-38.95%
FCF Yield
-79.47%-33.62%-95.57%-129.41%-158.28%-37.39%
Buyback Yield / Dilution
-19.49%-9.44%-32.04%-64.45%-32.43%-27.88%
SEC Filings: 10-K · 10-Q